Evidence map›Paper›PMID 42037556›Full record

ArticleChemistry & biodiversity2026

Antinociceptive Effect of Cinnamaldehyde in Male Mice: Investigation of the Mechanisms of Action Through In Silico and In Vivo Approaches.

Renaly I de A Rêgo, Hugo F O Pires, Arthur L Dias, Maria Caroline R B Remigio, Humberto H N de Andrade, Pablo R da Silva, Natália F de Sousa, Luciana Scotti, Marcus T Scotti, Mirian G S S Salvadori and 1 more

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Renaly I de A RêgoPostgraduate Program in Natural and Synthetic Bioactive Products, Center of Health Science, Federal University of Paraíba (UFPB), João Pessoa, Paraíba, Brazil.
Hugo F O PiresPostgraduate Program in Natural and Synthetic Bioactive Products, Center of Health Science, Federal University of Paraíba (UFPB), João Pessoa, Paraíba, Brazil.
Arthur L DiasPostgraduate Program in Natural and Synthetic Bioactive Products, Center of Health Science, Federal University of Paraíba (UFPB), João Pessoa, Paraíba, Brazil.
Maria Caroline R B RemigioPostgraduate Program in Natural and Synthetic Bioactive Products, Center of Health Science, Federal University of Paraíba (UFPB), João Pessoa, Paraíba, Brazil.
Humberto H N de AndradeInstitute of Research in Drugs and Medicines, Federal University of Paraíba (UFPB), João Pessoa, Paraíba, Brazil.
Pablo R da SilvaPostgraduate Program in Natural and Synthetic Bioactive Products, Center of Health Science, Federal University of Paraíba (UFPB), João Pessoa, Paraíba, Brazil.
Natália F de SousaPostgraduate Program in Natural and Synthetic Bioactive Products, Center of Health Science, Federal University of Paraíba (UFPB), João Pessoa, Paraíba, Brazil.
Luciana ScottiPostgraduate Program in Natural and Synthetic Bioactive Products, Center of Health Science, Federal University of Paraíba (UFPB), João Pessoa, Paraíba, Brazil.
Marcus T ScottiPostgraduate Program in Natural and Synthetic Bioactive Products, Center of Health Science, Federal University of Paraíba (UFPB), João Pessoa, Paraíba, Brazil.
Mirian G S S SalvadoriPostgraduate Program in Natural and Synthetic Bioactive Products, Center of Health Science, Federal University of Paraíba (UFPB), João Pessoa, Paraíba, Brazil.
Ricardo D de CastroPostgraduate Program in Natural and Synthetic Bioactive Products, Center of Health Science, Federal University of Paraíba (UFPB), João Pessoa, Paraíba, Brazil.ORCID https://orcid.org/0000-0001-7986-7376

Funding

Fundação de Apoio à Pesquisa do Estado da Paraíba (FAPESQ)Fundação de Apoio à Pesquisa do Estado da Paraíba - FAPESQ
6 · The paper itself

Abstract

Cinnamaldehyde (CA), a major component of Cinnamomum spp. essential oils, has recognized bioactivity, including possible analgesic effects. However, its acute antinociceptive mechanisms remain unclear. This study assessed the influence of CA (15, 30, and 60 mg/kg, p.o.) on locomotor and exploratory behaviors via rotarod and open field tests in male Swiss mice. Antinociceptive activity was evaluated using chemical and thermal nociception models. Mechanistic investigations were performed in the opioid and adrenergic systems, as well as in silico molecular docking in nociceptive targets. A significance level of p = 0.01 was adopted. CA significantly reduced nociceptive behaviors in all models without impairing motor coordination. In the formalin test, it inhibited neurogenic and inflammatory phases. In glutamate and capsaicin tests, CA markedly reduced nociceptive responses. In the hot plate test, it increased latency at 30 mg/kg. Naloxone reversed the antinociceptive effect of CA in the formalin test, supporting the hypothesis of opioid receptor involvement, while yohimbine partially blocked the response, suggesting α

Indexed as

AcroleinAnalgesicsPainAnimalsBehavior, AnimalCapsaicinDose-Response Relationship, DrugMaleMiceMolecular Docking SimulationReceptors, OpioidAcroleinAnalgesicsCapsaicincinnamaldehydeReceptors, Opioidcinnamaldehydenatural productsneurochemistrynociceptionpainphenylpropanoid

Identifiers

PMID42037556
PMCPMC13112334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.